US Business
Pfizer to Sell Vaccines, Drugs at Low Prices to Poorer Countries
The arrangement means that some of the drugs that carry list prices of tens of thousands of dollars a year in the U.S. would be substantially less for the low-income countries to buy, according to Pfizer.
